Ceftiofur is a semisynthetic broad-spectrum cephalosporin antibiotic, which acts against bacterial activity.
Ceftiofur is used as veterinary medicine for the treatment of respiratory disorders in beef or dairy cattle and pigs.

The global Ceftiofur market was valued at US$ XX million in 2019 and is expected to reach US$ XX million by the end of 2026, growing at a CAGR of XX% during 2021-2026.
This report focuses on Ceftiofur volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Ceftiofur market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.

Global Ceftiofur Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type
Ceftiofur Sodium
Ceftiofur Hydrochloride
Others

Segment by Application
Respiratory Infections
Urinary Tract Infections
Bovine Interdigital Necrobacillosis
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E

By Company
Pfizer
Novartis
Cadila Pharmaceuticals
AN PharmaTech
Norbrook Laboratories
Bayer
Zoetis
Cephazone Pharma
Ceva Sant Animale
HIPRA